0 XP   0   0   0

Cardiol Therapeutics Inc
Buy, Hold or Sell?

I guess you are interested in Cardiol Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Cardiol Therapeutics Inc

Let's start. I'm going to help you getting a better view of Cardiol Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Cardiol Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Cardiol Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Cardiol Therapeutics Inc. The closing price on 2021-10-11 was $3.41 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Cardiol Therapeutics Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Cardiol Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Cardiol Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cardiol Therapeutics Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -2,082.6% means that $-20.83 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cardiol Therapeutics Inc:

  • The MRQ is -8,330.3%. The company is making a huge loss. -2
  • The TTM is -2,082.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-8,330.3%TTM-2,082.6%-6,247.7%
TTM-2,082.6%YOY--2,082.6%
TTM-2,082.6%5Y-640.8%-1,441.8%
5Y-640.8%10Y-640.8%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,330.3%0.7%-8,331.0%
TTM-2,082.6%1.0%-2,083.6%
YOY-1.7%-1.7%
5Y-640.8%0.6%-641.4%
10Y-640.8%1.2%-642.0%
1.1.2. Return on Assets

Shows how efficient Cardiol Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cardiol Therapeutics Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -34.7% Return on Assets means that Cardiol Therapeutics Inc generated $-0.35 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cardiol Therapeutics Inc:

  • The MRQ is -17.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -34.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-34.7%+16.9%
TTM-34.7%YOY-18.5%-16.2%
TTM-34.7%5Y-24.9%-9.8%
5Y-24.9%10Y-24.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.9%0.2%-18.1%
TTM-34.7%0.2%-34.9%
YOY-18.5%0.1%-18.6%
5Y-24.9%-0.1%-24.8%
10Y-24.9%0.2%-25.1%
1.1.3. Return on Equity

Shows how efficient Cardiol Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cardiol Therapeutics Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -19.4% Return on Equity means the company generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cardiol Therapeutics Inc:

  • The MRQ is -19.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -40.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.4%TTM-40.2%+20.7%
TTM-40.2%YOY-19.8%-20.4%
TTM-40.2%5Y-36.5%-3.7%
5Y-36.5%10Y-36.5%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.4%0.8%-20.2%
TTM-40.2%0.6%-40.8%
YOY-19.8%0.6%-20.4%
5Y-36.5%0.1%-36.6%
10Y-36.5%0.5%-37.0%

1.2. Operating Efficiency of Cardiol Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cardiol Therapeutics Inc is operating .

  • Measures how much profit Cardiol Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cardiol Therapeutics Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cardiol Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-3.5%
TTM-2.3%-2.3%
YOY-3.9%-3.9%
5Y-3.5%-3.5%
10Y-1.9%-1.9%
1.2.2. Operating Ratio

Measures how efficient Cardiol Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 82.56 means that the operating costs are $82.56 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cardiol Therapeutics Inc:

  • The MRQ is 82.555. The company is inefficient in keeping operating costs low. -1
  • The TTM is 20.639. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ82.555TTM20.639+61.917
TTM20.639YOY-+20.639
TTM20.6395Y6.350+14.288
5Y6.35010Y6.3500.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ82.5551.480+81.075
TTM20.6391.435+19.204
YOY-1.383-1.383
5Y6.3501.363+4.987
10Y6.3501.160+5.190

1.3. Liquidity of Cardiol Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cardiol Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 12.27 means the company has $12.27 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cardiol Therapeutics Inc:

  • The MRQ is 12.270. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.519. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.270TTM9.519+2.751
TTM9.519YOY17.998-8.478
TTM9.5195Y14.484-4.965
5Y14.48410Y14.4840.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ12.2701.887+10.383
TTM9.5191.900+7.619
YOY17.9982.104+15.894
5Y14.4842.156+12.328
10Y14.4841.840+12.644
1.3.2. Quick Ratio

Measures if Cardiol Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 0.04 means the company can pay off $0.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cardiol Therapeutics Inc:

  • The MRQ is 0.039. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.098. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.039TTM0.098-0.059
TTM0.098YOY0.864-0.766
TTM0.0985Y0.436-0.338
5Y0.43610Y0.4360.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0390.641-0.602
TTM0.0980.784-0.686
YOY0.8640.809+0.055
5Y0.4360.838-0.402
10Y0.4360.834-0.398

1.4. Solvency of Cardiol Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cardiol Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.08 means that Cardiol Therapeutics Inc assets are financed with 8.2% credit (debt) and the remaining percentage (100% - 8.2%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Cardiol Therapeutics Inc:

  • The MRQ is 0.082. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.116. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.082TTM0.116-0.034
TTM0.116YOY0.064+0.052
TTM0.1165Y0.223-0.107
5Y0.22310Y0.2230.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0820.429-0.347
TTM0.1160.412-0.296
YOY0.0640.391-0.327
5Y0.2230.390-0.167
10Y0.2230.396-0.173
1.4.2. Debt to Equity Ratio

Measures if Cardiol Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 8.9% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cardiol Therapeutics Inc:

  • The MRQ is 0.089. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.133. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.133-0.044
TTM0.133YOY0.068+0.065
TTM0.1335Y1.011-0.878
5Y1.01110Y1.0110.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0890.688-0.599
TTM0.1330.677-0.544
YOY0.0680.624-0.556
5Y1.0110.678+0.333
10Y1.0110.689+0.322

2. Market Valuation of Cardiol Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Cardiol Therapeutics Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -3.57 means the investor is paying $-3.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cardiol Therapeutics Inc:

  • The EOD is -5.076. Company is losing money. -2
  • The MRQ is -3.572. Company is losing money. -2
  • The TTM is -4.037. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.076MRQ-3.572-1.503
MRQ-3.572TTM-4.037+0.464
TTM-4.037YOY-5.783+1.746
TTM-4.0375Y-3.750-0.286
5Y-3.75010Y-3.7500.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-5.0760.297-5.373
MRQ-3.5720.416-3.988
TTM-4.0371.360-5.397
YOY-5.7833.493-9.276
5Y-3.7506.176-9.926
10Y-3.7506.668-10.418
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Cardiol Therapeutics Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Cardiol Therapeutics Inc:

  • The MRQ is -0.065. Very Bad. -2
  • The TTM is -0.109. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.065TTM-0.109+0.043
TTM-0.109YOY0.097-0.206
TTM-0.1095Y-0.040-0.069
5Y-0.04010Y-0.0400.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0650.003-0.068
TTM-0.1090.020-0.129
YOY0.0970.032+0.065
5Y-0.0400.026-0.066
10Y-0.0400.029-0.069

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Cardiol Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 3.06 means the investor is paying $3.06 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cardiol Therapeutics Inc:

  • The EOD is 4.341. Neutral. Compare to industry.
  • The MRQ is 3.055. Neutral. Compare to industry.
  • The TTM is 4.697. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.341MRQ3.055+1.286
MRQ3.055TTM4.697-1.642
TTM4.697YOY3.164+1.533
TTM4.6975Y2.419+2.278
5Y2.41910Y2.4190.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD4.3411.424+2.917
MRQ3.0551.617+1.438
TTM4.6972.042+2.655
YOY3.1642.274+0.890
5Y2.4192.006+0.413
10Y2.4191.538+0.881

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cardiol Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.7860.593+32%0.462+70%0.325+142%0.325+142%
Book Value Per Share Growth--0.287-0.003+101%0.265+8%0.112+156%0.112+156%
Current Ratio--12.2709.519+29%17.998-32%14.484-15%14.484-15%
Debt To Asset Ratio--0.0820.116-29%0.064+29%0.223-63%0.223-63%
Debt To Equity Ratio--0.0890.133-33%0.068+31%1.011-91%1.011-91%
Dividend Per Share----0%-0%-0%-0%
Eps----0.1680%-0.1080%-0.1600%-0.1600%
Eps Growth--54.91253.398+3%-45.682+183%20.371+170%20.371+170%
Gains Per Share--0.287-0.003+101%0.265+8%0.112+156%0.112+156%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---83.303-20.826-75%--100%-6.408-92%-6.408-92%
Operating Margin----0%-0%-0%-0%
Operating Ratio--82.55520.639+300%-+100%6.350+1200%6.350+1200%
Pb Ratio4.341+30%3.0554.697-35%3.164-3%2.419+26%2.419+26%
Pe Ratio-5.076-42%-3.572-4.037+13%-5.783+62%-3.750+5%-3.750+5%
Peg Ratio---0.065-0.109+67%0.097-167%-0.040-39%-0.040-39%
Price Per Share3.410+30%2.4002.588-7%2.419-1%2.123+13%2.123+13%
Quick Ratio--0.0390.098-60%0.864-96%0.436-91%0.436-91%
Return On Assets---0.179-0.347+95%-0.185+4%-0.249+40%-0.249+40%
Return On Equity---0.194-0.402+107%-0.198+2%-0.365+88%-0.365+88%
 EOD+1 -2MRQTTM+11 -5YOY+9 -75Y+9 -710Y+9 -7

3.2. Fundamental Score

Let's check the fundamental score of Cardiol Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.076
Price to Book Ratio (EOD)Between0-14.341
Net Profit Margin (MRQ)Greater than0-83.303
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.039
Current Ratio (MRQ)Greater than112.270
Debt to Asset Ratio (MRQ)Less than10.082
Debt to Equity Ratio (MRQ)Less than10.089
Return on Equity (MRQ)Greater than0.15-0.194
Return on Assets (MRQ)Greater than0.05-0.179
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Cardiol Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.231
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2021-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets36,750
Total Liabilities3,012
Total Stockholder Equity33,737
 As reported
Total Liabilities 3,012
Total Stockholder Equity+ 33,737
Total Assets = 36,750

Assets

Total Assets36,750
Total Current Assets35,916
Long-term Assets35,916
Total Current Assets
Cash And Cash Equivalents 32,719
Net Receivables 114
Total Current Assets  (as reported)35,916
Total Current Assets  (calculated)32,833
+/- 3,083
Long-term Assets
Intangible Assets 421
Long-term Assets  (as reported)834
Long-term Assets  (calculated)421
+/- 413

Liabilities & Shareholders' Equity

Total Current Liabilities2,927
Long-term Liabilities85
Total Stockholder Equity33,737
Total Current Liabilities
Total Current Liabilities  (as reported)2,927
Total Current Liabilities  (calculated)0
+/- 2,927
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt137
Long-term Liabilities  (as reported)85
Long-term Liabilities  (calculated)137
+/- 52
Total Stockholder Equity
Total Stockholder Equity (as reported)33,737
Total Stockholder Equity (calculated)0
+/- 33,737
Other
Common Stock Shares Outstanding 42,947
Net Invested Capital 33,737
Net Working Capital 32,989



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
12,144
12,868
24,685
22,914
20,535
18,304
15,503
13,351
27,421
24,455
15,893
21,098
36,750
36,75021,09815,89324,45527,42113,35115,50318,30420,53522,91424,68512,86812,144
   > Total Current Assets 
11,453
12,192
24,027
22,271
19,627
17,199
14,371
12,257
26,383
23,467
14,950
20,209
35,916
35,91620,20914,95023,46726,38312,25714,37117,19919,62722,27124,02712,19211,453
       Cash And Cash Equivalents 
11,179
11,665
16,732
14,295
12,455
10,104
6,956
4,497
19,434
16,547
14,025
18,004
32,719
32,71918,00414,02516,54719,4344,4976,95610,10412,45514,29516,73211,66511,179
       Net Receivables 
149
326
461
634
452
590
928
1,093
176
282
220
316
114
1143162202821761,093928590452634461326149
       Other Current Assets 
58
0
6,346
3,807
5,084
5,084
0
0
0
0
0
0
0
00000005,0845,0843,8076,346058
   > Long-term Assets 
0
0
0
643
908
1,104
1,132
1,094
1,038
988
943
889
834
8348899439881,0381,0941,1321,104908643000
       Property Plant Equipment 
16
23
26
32
318
535
584
567
533
503
480
446
0
044648050353356758453531832262316
       Intangible Assets 
675
654
633
611
590
569
548
527
506
485
464
443
421
421443464485506527548569590611633654675
> Total Liabilities 
11,219
13,831
2,411
977
950
1,658
831
826
1,314
1,983
2,623
2,859
3,012
3,0122,8592,6231,9831,3148268311,6589509772,41113,83111,219
   > Total Current Liabilities 
1,168
1,253
2,141
977
796
1,510
691
695
1,191
1,869
2,518
2,764
2,927
2,9272,7642,5181,8691,1916956911,5107969772,1411,2531,168
       Accounts payable 
989
1,112
1,988
977
571
900
561
536
902
1,076
1,770
2,177
0
02,1771,7701,0769025365619005719771,9881,112989
       Other Current Liabilities 
0
0
10
0
0
0
0
0
0
0
0
0
0
00000000001000
   > Long-term Liabilities 
0
0
0
0
154
149
140
132
123
114
105
95
85
85951051141231321401491540000
> Total Stockholder Equity
925
-962
22,274
21,937
19,585
16,646
14,672
12,525
26,107
22,473
13,270
18,239
33,737
33,73718,23913,27022,47326,10712,52514,67216,64619,58521,93722,274-962925
   Common Stock
4,255
4,655
36,722
38,820
39,414
39,414
39,414
39,434
51,617
51,757
51,923
67,754
0
067,75451,92351,75751,61739,43439,41439,41439,41438,82036,7224,6554,255
   Retained Earnings -67,350-60,789-51,880-42,213-37,812-34,187-31,239-28,180-24,688-21,046-17,555-6,234-3,590
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
259
259
1,853
1,652
1,481
1,481
1,731
1,728
5,682
5,688
4,461
1,549
0
01,5494,4615,6885,6821,7281,7311,4811,4811,6521,853259259



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2020-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-20,690
Operating Income-20,690-20,690
 
Operating Expense (+$)
Research Development10,515
Selling General Administrative9,946
Selling And Marketing Expenses-
Operating Expense20,69020,461
 
Net Interest Income (+$)
Interest Income77
Interest Expense-0
Net Interest Income7777
 
Pretax Income (+$)
Operating Income-20,690
Net Interest Income77
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-20,641-20,663
EBIT - interestExpense = -18,883
-20,641
-20,641
Interest Expense0
Earnings Before Interest and Taxes (ebit)-18,883-20,641
Earnings Before Interest and Taxes (ebitda)-20,411
 
After tax Income (+$)
Income Before Tax-20,641
Tax Provision--
Net Income From Continuing Ops-20,641-20,641
Net Income-20,641
Net Income Applicable To Common Shares-20,641
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-27-77
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
UPSL.TA
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of UPSL.TA.

UPSL.TA Daily Candlestick Chart
ZMH.TA
2 hours ago

I found you a Bullish Three Line Strike Candle Pattern on the daily chart of ZMH.TA.

ZMH.TA Daily Candlestick Chart
SRFT.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SRFT.TA.

SRFT.TA Daily Candlestick Chart
NFTA.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
MSLA.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MSLA.TA.

MSLA.TA Daily Candlestick Chart
CAST.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CAST.TA.

CAST.TA Daily Candlestick Chart
HRON.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HRON.TA.

HRON.TA Daily Candlestick Chart
NAWI.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NAWI.TA.

NAWI.TA Daily Candlestick Chart
IBI.TA
2 hours ago

I found you a Death Cross on the daily chart of IBI.TA.

IBI.TA Daily Candlestick Chart
CBI.TA
2 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of CBI.TA.

CBI.TA Daily Candlestick Chart
MRIN.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MRIN.TA.

MRIN.TA Daily Candlestick Chart
ANLT.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ANLT.TA.

ANLT.TA Daily Candlestick Chart
ASHG.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ASHG.TA.

ASHG.TA Daily Candlestick Chart
WTS.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WTS.TA.

WTS.TA Daily Candlestick Chart
VCTR.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VCTR.TA.

VCTR.TA Daily Candlestick Chart
TOPS.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TOPS.TA.

TOPS.TA Daily Candlestick Chart
WSMK.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WSMK.TA.

WSMK.TA Daily Candlestick Chart
SPEN.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SPEN.TA.

SPEN.TA Daily Candlestick Chart
PRSK.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PRSK.TA.

PRSK.TA Daily Candlestick Chart
MZTF.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MZTF.TA.

MZTF.TA Daily Candlestick Chart
OPK.TA
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of OPK.TA.

OPK.TA Daily Candlestick Chart
AMAN.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AMAN.TA.

AMAN.TA Daily Candlestick Chart
MGOR.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MGOR.TA.

MGOR.TA Daily Candlestick Chart
MDIN-L.TA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MDIN-L.TA.

MDIN-L.TA Daily Candlestick Chart